Variant report
Variant | esv3458257 |
---|---|
Chromosome Location | chr2:125036511-125037213 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567811228 | chr2:125036553-125036554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533544460 | chr2:125036558-125036559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72962897 | chr2:125036571-125036572 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs74989293 | chr2:125036599-125036600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149639685 | chr2:125036604-125036605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549037644 | chr2:125036617-125036618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576219445 | chr2:125036681-125036682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377175559 | chr2:125036707-125036708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548286790 | chr2:125036756-125036757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10564494 | chr2:125036802-125036803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145790399 | chr2:125036813-125036814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs398060514 | chr2:125036824-125036825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200016280 | chr2:125036825-125036826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186258792 | chr2:125036826-125036827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146139047 | chr2:125036872-125036873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527739386 | chr2:125036909-125036910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6755697 | chr2:125036924-125036925 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs111898502 | chr2:125036926-125036927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533481474 | chr2:125036962-125036963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs707498 | chr2:125037046-125037047 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs1030531 | chr2:125037060-125037061 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs371322470 | chr2:125037074-125037075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116392028 | chr2:125037105-125037106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567821696 | chr2:125037153-125037154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367713928 | chr2:125037175-125037176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533606500 | chr2:125037191-125037192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553372720 | chr2:125037208-125037209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Developmental delay | 21147756 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:125025800-125041200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |